Deutsche Bank Aktiengesellschaft Reaffirms Buy Rating for Diploma (LON:DPLM)

Diploma (LON:DPLM)‘s stock had its “buy” rating reaffirmed by research analysts at Deutsche Bank Aktiengesellschaft in a research report issued on Tuesday, Digital Look reports. They currently have a GBX 4,500 ($56.53) price target on the stock. Deutsche Bank Aktiengesellschaft’s target price points to a potential upside of 20.06% from the company’s previous close.

Several other research firms have also recently commented on DPLM. Berenberg Bank lifted their target price on shares of Diploma from GBX 3,800 ($47.74) to GBX 4,400 ($55.28) and gave the stock a “buy” rating in a research report on Thursday, March 28th. Shore Capital reiterated a “buy” rating on shares of Diploma in a research note on Wednesday, March 27th. One equities research analyst has rated the stock with a sell rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of GBX 3,712.50 ($46.64).

Diploma Trading Up 1.0 %

LON:DPLM traded up GBX 38 ($0.48) during trading hours on Tuesday, hitting GBX 3,748 ($47.09). 11,223,213 shares of the company were exchanged, compared to its average volume of 291,549. The company has a fifty day simple moving average of GBX 3,533.12 and a 200 day simple moving average of GBX 3,371.60. The company has a current ratio of 2.06, a quick ratio of 0.80 and a debt-to-equity ratio of 44.05. The stock has a market capitalization of £5.02 billion, a price-to-earnings ratio of 4,116.48, a price-to-earnings-growth ratio of 2.82 and a beta of 0.73. Diploma has a one year low of GBX 2,636 ($33.12) and a one year high of GBX 3,870 ($48.62).

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.